0001437749-23-024470.txt : 20230822 0001437749-23-024470.hdr.sgml : 20230822 20230822194520 ACCESSION NUMBER: 0001437749-23-024470 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230820 FILED AS OF DATE: 20230822 DATE AS OF CHANGE: 20230822 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mendelsohn Alan CENTRAL INDEX KEY: 0001842511 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37411 FILM NUMBER: 231194903 MAIL ADDRESS: STREET 1: C/O TIMBER PHARMACEUTICALS, INC. STREET 2: 50 TICE BLVD., SUITE A26 CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER NAME: FORMER CONFORMED NAME: Mendelsohn Dr. Alan DATE OF NAME CHANGE: 20210126 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Timber Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001504167 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 593843182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: (917) 697-3130 MAIL ADDRESS: STREET 1: 3 MOUNTAINVIEW ROAD, SUITE 100 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: BioPharmX Corp DATE OF NAME CHANGE: 20140304 FORMER COMPANY: FORMER CONFORMED NAME: THOMPSON DESIGNS INC DATE OF NAME CHANGE: 20101022 4 1 rdgdoc.xml MENDELSOHN FORM 4 X0508 4 2023-08-20 0001504167 Timber Pharmaceuticals, Inc. TMBR 0001842511 Mendelsohn Alan C/O TIMBER PHARMACEUTICALS, INC. 3 MOUNTAINVIEW RD, SUITE 100 WARREN NJ 07059 1 EVP & CMO 0 Common Stock, par value $0.001 per share 2023-08-20 4 A 0 35193 0 A 35393 D Common Stock, par value $0.001 per share 39 I By spouse On August 20, 2023, the Reporting Person was granted 35,193 restricted stock units ("RSUs"), which will be settled in shares of common stock, par value $0.001. 25% of the RSUs vest on August 20, 2024, and the remaining RSUs vest in 36 equal monthly installments beginning on September 20, 2024, as long as the Reporting Person remains in continuous service with the Issuer through each vesting date; provided, however, that the RSUs will vest in full in the event that a "Change in Control" (as defined in the Issuer's 2020 Omnibus Incentive Plan) occurs while the Reporting Person remains in continuous service with the Issuer. /s/ Joseph Lucchese, Power of Attorney 2023-08-22